FindTrial
Sign In

Retrospective study based on drug-drug interaction in neonates

Assessment of potential drug-drug interactions in neonatal intensive care unit: a retrospective study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091567
Enrollment
240
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervention5: Nil: Nil Intervention6: Nil: Nil

Sponsors

NGSM Institute of Pharmaceutical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonates(less than 28days) who have been admitted in NICU department at KS Hegde hospital, Neonates prescribed with at least 2 medications, All neonates both preterm and term will be included, Neonates with clear and complete patient data will be included.

Exclusion criteria

Exclusion criteria: Neonates born in any other hospital other than Justice KS Hedge Charitable hospital will be excluded.

Design outcomes

Primary

MeasureTime frame
Common DDIs among neonates can be identified and categorized based on severity.Timepoint: 8 months—

Secondary

MeasureTime frame
Length of hospital stay can be correlated with the number of DDIs.Timepoint: 8 months—

Countries

India

Contacts

Public ContactDr Uday Venkat Mateti

NGSM Institute of Pharmaceutical Sciences

udeyv@nitte.edu.in8152977460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026